Page 2 - Zydus Cadila

Zydus Cadila testing a multi-variant Covid-19 vaccine on animals

Mixing multiple strains to get what is called a multi-variant vaccine may be a way to get better immunity, scientists feel

Zydus to knock Covid vax price to Rs 265 a dose, decision soon: Sources

Zydus Cadila has agreed to bring down the price of its Covid vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday.

Zydus Cadila's Covid vaccine will be rolled out soon: V K Paul

'We will take a final decision based on the overall scientific rationale and the supply situation of the child licenced vaccines, going forward,' says Covid Task Force chief

Zydus Cadila gets tentative nod from USFDA to market generic acne drug

Drug firm Zydus Cadila on Friday said it has received tentative nod from the US health regulator to market generic Adapalene and Benzoyl Peroxide gel used for treatment of acne in the American market. The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3 per cent/2.5 per cent, Zydus Cadila said in a statement. The drug will be manufactured at the group's topical plant at Ahmedabad, it added. Adapalene and Benzoyl Peroxide combination is used to treat acne. It works by killing the bacteria that cause acne and by keeping the skin pores clean, Zydus Cadila said. The group now has 323 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of its filing process, it added. Shares of Cadila Healthcare, the listed entity of the group, were trading at Rs 550.55 per scrip on BSE, up 0.18 per cent from their previous close.

Zydus Cadila proposes Rs 1900 for 3 dose Covid vaccine; Govt negotiating

As far as the price of the vaccine at which it will be procured is concerned, Union Health Secretary Rajesh Bhushan said the government is in conversation with the manufacturers

Centre hopeful of positive outcome with Zydus Cadila for Covid vaccine

Centre is hopeful of a positive outcome from final round of discussions currently underway with Zydus Cadila for its Covid vaccine for children, Karnataka Health Minister K Sudhakar

Covid: Talks on to make ZyCoV-D part of inoculation programme, says govt

Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people, a decision will be taken soon to make it a part of the country's vaccination programme

Zydus Cadila gets USFDA nod to market depression treatment drug in US

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Vortioxetine Tablets, used to treat depression, in the American market.

Zydus Cadila gets USFDA approval for schizophrenia treatment drug

Drug firm Zydus Cadila on Thursday said it has received approval from the US health regulator to market Brexpiprazole tablets, used for the treatment of schizophrenia, in the American market.

Zydus Cadila gets USFDA's approval to market diabetes medication

Drug firm Zydus Cadila on Monday said it has received approval from the US health regulator to market Sitagliptin, a medicine indicated to treat diabetes.

Zydus Cadila's Covid-19 vaccine can be available from first week of Oct

The Union government is expecting Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D to be available from the first week of October. Further, a decision on whether all children or only those with co-morbidities will be administered the COVID-19 vaccine on priority has not yet been taken, the government said on Thursday. Indigenously developed Zydus Cadila's ZyCoV-D on Friday received approval for Emergency Use Authorisation from the drug regulator, making it the first vaccine in the country which would be administered in the age group of 12-18 years. On the kind of negotiations in terms of pricing and when the government plans to procure ZyCoV-D, Union Health Secretary Rajesh Bhushan said, "Coming to negotiations, what we have understood from media reports as well as our own engagement with the vaccine manufacturing company is that they would be in a position to make available this vaccine from the first week of October." "So we are in talks with them and the moment we crystallise

Sensex gains after 2-day hiatus, ends 226 pts up; broader indices decline

Sectorally, the Nifty IT index advanced 2 per cent while the Nifty Auto index tumbled 1.5 per cent

Zydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivity

Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Tofacitinib extended-release tablets, used to treat rheumatoid arthritis, in the American market

Zydus to soon start work on developing a vaccine for Delta variant

Also plans trials for children aged three years and above. Its needle-free injection is to be assembled in India

Will take 4-5 months to publish Phase-3 trial data of ZyCoV-D: Zydus MD

The Ahmedabad-based pharma company has received approval from DCGI for ZyCOV-D, the world's first and India's indigenously developed DNA-based vaccine for Covid

Will have clarity on price of ZyCoV-D next week, says Zydus Group MD

Supply of ZyCoV-D to start from mid-Sept, says Dr. Sharvil Patel

Top headlines: Tariff troubles for telcos, India's Covid jab for children

Business Standard brings you the top stories for the day

Top headlines: Sonia urges Oppn to plan for 2024 polls; Zydus gets SEC nod

Business Standard brings you the top stories this evening

India approves Zydus' DNA-based three-dose Covid vaccine for emergency use

Adolescents in the age group of 12-18 years can take the shot in India

Expert panel green signals Cadila's 3-dose DNA plasmid vaccine ZyCoV-D

DCGI nod expected soon; vaccine stable at room temperatures